Marancial, Sarlinda S.
HRN: 26-16-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/03/2024
11/10/2024
IVTT
500
Q8
Hemorrhoids
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes